Skip to main content
SpringerLink
Log in

Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate

  • Chapter
Systemic Lupus Erythematosus

  • 116 Accesses

Summary

In systemic lupus erythematosus (SLE), neurological involvement has been reported to occur with frequencies ranging from 14% (severe cases) to 83% (mild forms included). In spite of early diagnosis and aggressive treatment, neuropsychiatric SLE may represent a serious problem of management. We describe three cases, one with acute transverse myelitis, one with hemiparesis, and one with signs of focal and diffuse cerebral dysfunction, in whom improvement following intrathecal therapy with methotrexate and dexamethasone was observed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abel T, Gladman DD, Urowitz MB (1980) Neuropsychiatric lupus. J Rheumatol 7: 325

    CAS  PubMed  Google Scholar 

  2. Adelman DC, Saltiel E, Klineberg JR (1986) Neuropsychiatric manifestations of systemic lupus erythematosus: an overview. Semin Arthritis Rheum 15: 185

    Article  CAS  PubMed  Google Scholar 

  3. Asherson RA, Mercey D, Phillips G, Sheehan N, Gharavi AB, Harris EN, Hughes GRV (1987) Recurrent stroke and multiinfarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis 46: 605

    Article  CAS  PubMed  Google Scholar 

  4. Asherson RA, Khamashta MA, Gil A, Vaquez JJ, Chan O, Baguley E, Hughes GRV (1989) Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease and the primary antiphospholipid antibody syndrome. Am J Med 86: 391

    Article  CAS  PubMed  Google Scholar 

  5. Balis FM, Lester CM, Chrousos GP, Heidman RL (1987) Differences in cerebrospinal fluid penetration of corticosteroid: possible relationship to the prevention of meningeal leukemia. J Clin Oncol 5: 5202

    Google Scholar 

  6. Blaney SM, Balis FM, Poplak DG (1991) Current pharmacological treatment approaches to central nervous system leukemia. Drugs 41: 702

    Article  CAS  PubMed  Google Scholar 

  7. Bleyer WA (1981) Neurologic sequelae of methotrexate and ionizing radiation: a new classification. Cancer Treat Rep 65 [Suppl 1]: 89

    PubMed  Google Scholar 

  8. Boumpas DT, Patronas NJ, Dalakas MR, Hakin CA, Klippel JH, Balow JE (1990)Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol 17: 89

    CAS  PubMed  Google Scholar 

  9. Brinciotti M, Ferrucci G, Trasatti G, Priori R, Squilloni E, Valesini G (1993) Case report: reflex seizures as initial manifestation of systemic lupus erythematosus in childhood. Lupus 2: 281

    CAS  PubMed  Google Scholar 

  10. Creighton WD, Lambert PH, Miescher PA (1973) Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol. J Immunol 111: 1219

    CAS  PubMed  Google Scholar 

  11. Dubois EL, Wallace DJ (1987) Clinical and laboratory manifestations of SLE. In: Wallace DJ, Dubois EL (eds) SLE, 3rd edn, Lea and Fabiger, Philadelphia, pp 385–403

    Google Scholar 

  12. Ellis SG, Verity MA (1979) Central nervous system involvement in systemic lupus erythematosus. A review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthitis Rheum 8: 212

    Article  CAS  Google Scholar 

  13. Feinglass EJ, Arnett FC, Dorsch CA, Zizic T, Stevens MB (1976) Neuropsychiatric manifestations in systemic lupus erythematosus: diagnosis, clinical spectrum and the relationship to other features of the disease. Medicine 55: 323

    Article  CAS  PubMed  Google Scholar 

  14. Fruchter L, Gauthier B, Marino F (1983) The use of plasmapheresis in a patient with systemic lupus erythematosus and necrotizing cutaneous ulcers. J Rheumatol 10: 341

    CAS  PubMed  Google Scholar 

  15. Ginzler EM, Shorn K (1988) Outcome and prognosis in systemic lupus erythematosus. Rheum Dis Clin North Am 14: 67

    CAS  PubMed  Google Scholar 

  16. Gladman DD (1991) Prognosis of systemic lupus erythematosus and the factors that affect it. Curr Opin Rheumatol 3: 789

    Article  CAS  PubMed  Google Scholar 

  17. Goldstein M, Meyer O, Bourgeois P, Palazzo E, Nicaise P, Labarre C, Kahn MF (1993) Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies. Clin Exp Rheumatol 11: 373

    Google Scholar 

  18. Hachen HJ, Chantraine A (1979) Spinal cord involvement in SLE. Paraplegia 17: 337

    Article  CAS  PubMed  Google Scholar 

  19. Hanly JG (1992) Nervous system involvement in systemic lupus erythematosus. Transfus Sci 13: 145

    Article  Google Scholar 

  20. Hay EM, Isemberg DA (1993) Autoantibodies in central nervous system lupus. Br J Rheumatol 32: 329

    Article  CAS  PubMed  Google Scholar 

  21. Kaplan RS, Wirnik PH (1982) Neurotoxicity of antineoplastic drugs. Semin Oncol 9: 103

    CAS  PubMed  Google Scholar 

  22. Lavalle C, Pizzarro S, Drenkard C, Sanchez Guerrero J, Alarcon Segovia D (1990) Transverse myelitis: a manifestation of systemic lupus erythematosus associated with antiphospholipid antibodies. J Rheumatol 17: 34

    CAS  PubMed  Google Scholar 

  23. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN (1985) Measurement of anticardiolipin antibodies by enzyme-linked immunoabsorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 62: 738

    CAS  PubMed  Google Scholar 

  24. McCune JW, Golbus J (1988) Neuropsychiatric lupus. Rheum Dis Clin North Am 14: 149

    CAS  PubMed  Google Scholar 

  25. Medina Rodriguez F, Garcia E, Frago A (1990) Transverse myelitis and antiphospholipid antibodies. J Rheumatol 17: 1250

    CAS  PubMed  Google Scholar 

  26. Misteli LM, Conen D (1991) Acute Transverse myelitis in systemic lupus erythematosus: successful therapy with cyclophosphamide and prednisone. Ter Arkh 63: 77

    Google Scholar 

  27. Olsen EA (1991) The pharmacology of methotrexate. J Am Acad Dermatol 25: 306

    Article  CAS  PubMed  Google Scholar 

  28. Omdal R, Mellgren SI, Husby G (1988) Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus. Scand J Rheumatol 17: 113

    Article  CAS  PubMed  Google Scholar 

  29. Priori R, Llitta A, Valesini G (1990) Manifestazioni neurologiche e psichiatriche nel lupus eritematoso sistemico. Folia Allergol Immunol Clin 4: 187

    Google Scholar 

  30. Propper DJ, Bucknall RC (1989) Acute transverse myelitis complicating systemic lupus erythematosus. Ann Rheum Dis 48: 512

    Article  CAS  PubMed  Google Scholar 

  31. Rosner G, Ginzler EM, Diamond HS et al (1985) A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthitis Rheum 25: 612

    Article  Google Scholar 

  32. Sands ML, Ryczak M, Brown RB (1988) Recurrent aseptic meningitis followed by transverse myelitis as a presentation of systemic lupus erythematosus. J Rheumatol 15: 862

    CAS  PubMed  Google Scholar 

  33. Swaak AJG, Nossent JC, Bronsveld W, van Rooyen A, Nieuwenhuys EJ, Theuns L, Smeenk TJT (1989) Systemic lupus erythematosus. I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann Rheum Dis 48: 447

    Article  CAS  PubMed  Google Scholar 

  34. Teh LS, Hay M, Amos N, Huddy A, Creed F, Bernstein RM, Holt PJL, Williams BD (1993) Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosus. Br J Rheumatol 32: 287

    Article  CAS  PubMed  Google Scholar 

  35. Tola MR, Granieri E, Caniatti L, Paolino E, Monetti C, Dovigo L, Scolozzi R, De Bastiani P, Carreras M (1992) Systemic lupus erythematosus presenting with neurological disorders. J Neurol 239: 61

    Article  CAS  PubMed  Google Scholar 

  36. van Dam AP (1991) Diaguosis and pathogenesis of CNS lupus. Rheumatol Int 11: 1

    Article  PubMed  Google Scholar 

  37. van der Kaaden AJ, Kamphuis DJ, Nossent JC, Rico RE (1993) Longstanding isolated cerebral systemic lupus erythematosus in an eight year-old Black girl. Clin Neurol Neurosurg 95: 241

    Article  PubMed  Google Scholar 

  38. Wilke WS, Krall PL, Scheetz RJ, Babiak T, Danao T, Mazanec DJ, Segal AM, Clough JD (1991) Methotrexate for systemic lupus erythematosus: a retrospective analysis of 17 unselected cases. Clin Exp Rheumatol 9: 581

    CAS  PubMed  Google Scholar 

  39. Zerbini CAF, Fidelix TSA, Rabello GD (1986) Recovery from transverse myelitis of systemic lupus erythematosus with steroid therapy. J Neurol 233: 188

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica Medica I, Università “La Sapienza”, Viale del Policlinico, 1-00161, Rome, Italy

    G. Valesini & R. Priori

  2. III Clinica Neurologica, Università “La Sapienza”, Rome, Italy

    A. Francia

  3. Servizio di Immunologia Clinica, Ospedali Civile, Brescia, Italy

    G. Balestrieri, A. Tincani, P. Airo, R. Cattaneo & A. Zambruni

  4. I Divisione Neurologia, Ospedali Civile, Brescia, Italy

    B. Troianello

  5. Hôpital Cantonal Universitaire, Genéve, Switzerland

    M. Chofflon & P. A. Miescher

Authors
  1. G. Valesini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Priori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Francia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Balestrieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Tincani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Airo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Cattaneo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Zambruni
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B. Troianello
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Chofflon
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. P. A. Miescher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division d’Hématologie, Centre de Transfusion Sanguine, Hôpital Cantonal Universitaire, 25, rue Micheli-du-Crest, CH-1211, Geneva 4, Switzerland

    Peter A. Miescher

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Valesini, G. et al. (1995). Central nervous system involvement in systemic lupus erythematosus: a new therapeutic approach with intrathecal dexamethasone and methotrexate. In: Miescher, P.A. (eds) Systemic Lupus Erythematosus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79622-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79622-7_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-79624-1

  • Online ISBN: 978-3-642-79622-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation